DCOY
Decoy Therapeutics Inc.Company Information
- Company Name
- Decoy Therapeutics Inc.
- CIK
- CIK0001615219
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- DCOY: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- DCOY
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-11-20
- Last sale
- 2025-12-30
- Shares purchased (TTM)
- 25,000
- Shares sold (TTM)
- 12
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 4,317
- Shares outstanding
- 531,968
- Ownership
- 0.81%
Earnings Market Reaction
- Filing date
- 2026-08-12
- Price on filing date
- —
- 1-month reaction
- -25.28%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0 | 1 | 0 | - | 0 | 0 | 0 | - | - | - | - | - | ||||||
| Preferred Stock | 0 | 0 | 0 | - | - | - | 0 | - | - | - | - | - | ||||||
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 8 | 8 | 11 | 5 | 1 | 2 | 2 | 3 | 3 | 4 | 6 | 8 | ||||||
| Prepaid Expense And Other Assets Current | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | ||||||
| Grants Receivable Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Assets Current | 9 | 8 | 11 | 6 | 1 | 2 | 3 | 4 | 4 | 5 | 7 | 8 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | - | - | - | 0 | - | - | - | - | - | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 9 | 8 | 11 | 6 | 1 | 2 | 3 | 4 | 4 | 5 | 7 | 8 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | ||||||
| Deferred Revenue | 3 | 3 | 3 | - | - | - | 0 | - | - | - | - | - | ||||||
| Notes Payable Current | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Related Party Deposit Liabilities | 0 | 0 | 0 | - | - | - | 0 | - | - | - | - | - | ||||||
| Other Liabilities Current | - | - | 0 | - | - | - | 0 | - | - | - | - | - | ||||||
| Liabilities Current | 5 | 5 | 5 | - | - | - | 2 | - | - | - | - | - | ||||||
| Liabilities | 5 | 5 | 5 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | ||||||
| Preferred Stock Value | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 103 | 101 | 100 | 90 | 84 | 84 | 83 | 83 | 82 | 82 | 82 | 82 | ||||||
| Retained Earnings Accumulated Deficit | -99 | -97 | -94 | -85 | -85 | -84 | -82 | -80 | -79 | -78 | -76 | -75 | ||||||
| Stockholders Equity | 4 | 4 | 6 | 4 | -1 | 0 | 2 | 3 | 2 | 4 | 5 | 6 | ||||||
| Preferred Stock Shares Outstanding | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities And Stockholders Equity | 9 | 8 | 11 | 6 | 1 | 2 | 3 | 4 | 4 | 5 | 7 | 8 | ||||||
| Preferred Stock Par Or Stated Value Per Share | - | - | - | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | - | - | - | - | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 100 | 100 | - | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | ||||||
| Common Stock Shares Issued | 1 | 1 | - | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Shares Outstanding | 1 | 1 | - | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialDecoy Therapeutics Inc. (DCOY) — SEC Financial Statements & Analysis
Decoy Therapeutics Inc. (DCOY) is a pharmaceutical preparations company, incorporated in DE. Decoy Therapeutics Inc. trades on Nasdaq as: DCOY. Decoy Therapeutics Inc. (DCOY)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12. Based on that filing, Decoy Therapeutics Inc. carries a market cap of $3.82M, a P/E ratio of -0.26x, a P/B ratio of 0.89x, a P/S ratio of 16.80x, an enterprise value of $-4.46M, and an EV/EBITDA multiple of 0.30x. On profitability, it posts an operating margin of -6521.34%, a net margin of -6347.85%, a Return on Equity (ROE) of -827.77%, a Return on Assets (ROA) of -278.04%, and a Return on Invested Capital (ROIC) of -1341.19%. Per share, it reports EPS of $-27.16, diluted EPS of $-27.16, free cash flow per share of $-15.65, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of 183.14% year-over-year and EPS growth of -93.72% year-over-year. On the balance sheet, it maintains a current ratio of 1.83x, a quick ratio of 1.77x, working capital of $3.89M, a debt-to-equity ratio of 1.08x, a debt ratio of 0.52, an interest coverage ratio of -88.74x, free cash flow of $-8.32M (TTM), and net debt of $-8.29M. Figures sourced from SEC EDGAR.
- Market Cap
- $3.82M
- P/E TTM
- -0.26x
- EPS TTM
- $-27.16
- P/B TTM
- 0.89x
- ROE TTM
- -827.77%
- ROA TTM
- -278.04%
- Debt To Equity
- 1.08x
- Free Cash Flow TTM
- $-8.32M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Decoy Therapeutics Inc. in?
Decoy Therapeutics Inc. (DCOY) operates in the Pharmaceutical Preparations industry.
What exchange does DCOY trade on?
Decoy Therapeutics Inc. (DCOY) trades on the Nasdaq.
Where is Decoy Therapeutics Inc. incorporated?
Decoy Therapeutics Inc. is incorporated in DE.
When was Decoy Therapeutics Inc. (DCOY)'s most recent SEC filing?
Decoy Therapeutics Inc. (DCOY)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12.
What is DCOY's market cap?
Decoy Therapeutics Inc. (DCOY) has a market capitalization of $3.82M as of 2026-06-30.
What is DCOY's EPS (earnings per share)?
Decoy Therapeutics Inc. (DCOY)'s trailing twelve month EPS is $-27.16 as of 2026-06-30.
What is DCOY's ROE (return on equity)?
Decoy Therapeutics Inc. (DCOY)'s trailing twelve month Return on Equity (ROE) is -827.77% as of 2026-06-30.
What is DCOY's ROA (return on assets)?
Decoy Therapeutics Inc. (DCOY)'s trailing twelve month Return on Assets (ROA) is -278.04% as of 2026-06-30.
What is DCOY's ROIC (return on invested capital)?
Decoy Therapeutics Inc. (DCOY)'s trailing twelve month Return on Invested Capital (ROIC) is -1341.19% as of 2025-12-31.
What is DCOY's EV/EBITDA?
Decoy Therapeutics Inc. (DCOY)'s trailing twelve month EV/EBITDA is 0.30x as of 2026-06-30.